Two-component vasopressor therapy for septic shock
The objective: to investigate the efficacy and safety of terlipressin when it is used as an additional vasopressor in septic shock.Subjects: A single-center, observational, retrospective-prospective study of the efficacy and safety of combined therapy of septic shock with norepinephrine and terlipre...
Saved in:
| Main Authors: | A. A. Kochkin, V. V. Likhvantsev, К. К. Kadantseva |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
New Terra Publishing House
2021-03-01
|
| Series: | Вестник анестезиологии и реаниматологии |
| Subjects: | |
| Online Access: | https://www.vair-journal.com/jour/article/view/498 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Modern Vasopressor Therapy of Septic Shock (Review)
by: A. A. Kochkin, et al.
Published: (2020-04-01) -
Time to vasopressor initiation and organ failure progression in early septic shock
by: Lauren Page Black, et al.
Published: (2020-06-01) -
Angiotensin II therapy in refractory septic shock: which patient can benefit most? A narrative review
by: Irene Coloretti, et al.
Published: (2024-02-01) -
Selection of Target Mean Arterial Pressure in Severely Burned Patients with Septic Shock
by: A. A. Kleuzovich, et al.
Published: (2022-12-01) -
Predictors of Lethal Outcomes in Patients with Refractory Septic Shock
by: А. А. Kochkin, et al.
Published: (2021-07-01)